Clinical Trials
5 trialsNCT03702231 2023-08-04
Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT01798056 2021-05-13
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy
GlaxoSmithKline
Phase 3 Completed
NCT01254630 2019-09-30
V212-011
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT01460719 2019-03-11
V212-013
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT01767467 2018-06-06
Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood Cancers
GlaxoSmithKline
Phase 3 Completed